BRIEF-Celgene says intends to vigorously enforce extensive intellectual property rights for REVLIMID

Aug 25 (Reuters) - Celgene Corp:

* Expects to receive a paragraph IV notification of an ANDA filing for REVLIMID

* Says not yet received the paragraph IV notification letter identifying the

filer

* Says intends to vigorously enforce its extensive intellectual property rights

for Revlimid

* Will file a complaint alleging infringement of Celgene patents after the

notification letter is received

((Bangalore Equities Newsroom; [phone]; within U.S. [phone]))

(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.